APA (7th ed.) Citation

Raynes, G., Price, G., Yan, X., Barrie, C., Maclennan, K., Campbell, S., . . . Stares, M. (2022). 69 - The Scottish Inflammatory Prognostic Score (SIPS) identifies poor responders to first-line chemoimmunotherapy in non-small cell lung cancer. Lung Cancer (01695002), 165, S33. https://doi.org/10.1016/S0169-5002(22)00116-7

Chicago Style (17th ed.) Citation

Raynes, George, et al. "69 - The Scottish Inflammatory Prognostic Score (SIPS) Identifies Poor Responders to First-line Chemoimmunotherapy in Non-small Cell Lung Cancer." Lung Cancer (01695002) 165 (2022): S33. https://doi.org/10.1016/S0169-5002(22)00116-7.

MLA (9th ed.) Citation

Raynes, George, et al. "69 - The Scottish Inflammatory Prognostic Score (SIPS) Identifies Poor Responders to First-line Chemoimmunotherapy in Non-small Cell Lung Cancer." Lung Cancer (01695002), vol. 165, 2022, p. S33, https://doi.org/10.1016/S0169-5002(22)00116-7.